Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
SaleCommon Stock | 1,010 | $206.54 | $208,605.40 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 4 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,095 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
SaleCommon Stock | 600 | $209.00 | $125,400.00 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,105 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
Disposition to issuerCommon Stock | 2,454 | $209.00 | $512,886.00 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,705 Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 20:43 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
Exercise / conversionCommon Stock | 3,054 | $167.91 | $512,797.14 |
DisclosureSEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 19:54 UTC |
Shan DavidEVP and Chief ISC Officer
|
Tax withholdingCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001963048-26-000002 · wk-form4_1767729284.xml · nonDerivative · entry 1 Shan David · CIK 0001963048 · EVP and Chief ISC Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,926 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards. Read SEC document |
| December 26, 2025 Filed Dec 29, 2025 12:00 UTC |
Feld MichaelEVP, CRO & Pres. Life Sciences
|
SaleCommon Stock | 74 | $196.08 | $14,509.92 |
DisclosureSEC source: 0001628280-25-058843 · wk-form4_1767009647.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,506 Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 01:12 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
SaleCommon Stock | 629 | $196.03 | $123,302.87 |
DisclosureSEC source: 0001628280-25-057774 · wk-form4_1766020374.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,105 Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 19:58 UTC |
Wright JacquelineDirector
|
GrantCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054703 · wk-form4_1764705516.xml · nonDerivative · entry 1 Wright Jacqueline · CIK 0001806405 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 23:25 UTC |
Feld MichaelEVP, CRO & Pres. Life Sciences
|
SaleCommon Stock | 75 | $193.36 | $14,502.00 |
DisclosureSEC source: 0001628280-25-054855 · wk-form4_1764717914.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,580 Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 19:55 UTC |
Huffines Robert LutherDirector
|
GrantCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054700 · wk-form4_1764705302.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 18:25 UTC |
Mocherla Pavan KumarEVP & President, Greater Asia
|
GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054380 · wk-form4_1764613508.xml · nonDerivative · entry 2 Mocherla Pavan Kumar · CIK 0001936972 · EVP & President, Greater Asia 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,763 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 18:25 UTC |
Mocherla Pavan KumarEVP & President, Greater Asia
|
GrantCommon Stock | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054380 · wk-form4_1764613508.xml · nonDerivative · entry 1 Mocherla Pavan Kumar · CIK 0001936972 · EVP & President, Greater Asia 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,055 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 18:20 UTC |
Shan DavidEVP and Chief ISC Officer
|
Tax withholdingCommon Stock | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054375 · wk-form4_1764613243.xml · nonDerivative · entry 3 Shan David · CIK 0001963048 · EVP and Chief ISC Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,970 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 18:20 UTC |
Shan DavidEVP and Chief ISC Officer
|
GrantCommon Stock | 1,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054375 · wk-form4_1764613243.xml · nonDerivative · entry 2 Shan David · CIK 0001963048 · EVP and Chief ISC Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,104 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 18:20 UTC |
Shan DavidEVP and Chief ISC Officer
|
GrantCommon Stock | 3,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054375 · wk-form4_1764613243.xml · nonDerivative · entry 1 Shan David · CIK 0001963048 · EVP and Chief ISC Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,079 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:30 UTC |
Neal Shana CarolEVP and Chief People Officer
|
Tax withholdingCommon Stock | 2,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054360 · wk-form4_1764610253.xml · nonDerivative · entry 3 Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,326 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:30 UTC |
Neal Shana CarolEVP and Chief People Officer
|
GrantCommon Stock | 3,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054360 · wk-form4_1764610253.xml · nonDerivative · entry 2 Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,780 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:30 UTC |
Neal Shana CarolEVP and Chief People Officer
|
GrantCommon Stock | 6,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054360 · wk-form4_1764610253.xml · nonDerivative · entry 1 Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,255 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:12 UTC |
Goette RolandEVP and President, EMEA
|
Tax withholdingCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054354 · wk-form4_1764609141.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,222 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:12 UTC |
Goette RolandEVP and President, EMEA
|
GrantCommon Stock | 1,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054354 · wk-form4_1764609141.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,360 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:12 UTC |
Goette RolandEVP and President, EMEA
|
GrantCommon Stock | 1,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054354 · wk-form4_1764609141.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,123 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:06 UTC |
Feld MichaelEVP, CRO & Pres. Life Sciences
|
Tax withholdingCommon Stock | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054349 · wk-form4_1764608782.xml · nonDerivative · entry 2 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,655 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:06 UTC |
Feld MichaelEVP, CRO & Pres. Life Sciences
|
GrantCommon Stock | 8,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054349 · wk-form4_1764608782.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,074 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
Tax withholdingCommon Stock | 1,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 3 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,734 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
GrantCommon Stock | 3,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 2 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,503 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:09 UTC |
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
|
GrantCommon Stock | 7,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054351 · wk-form4_1764608979.xml · nonDerivative · entry 1 Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,455 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:02 UTC |
DelOrefice ChristopherEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 4,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054346 · wk-form4_1764608555.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,982 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:02 UTC |
DelOrefice ChristopherEVP & Chief Financial Officer
|
GrantCommon Stock | 6,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054346 · wk-form4_1764608555.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,227 F1 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:59 UTC |
Byrd RichardEVP & President Interventional
|
Tax withholdingCommon Stock | 1,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054344 · wk-form4_1764608369.xml · nonDerivative · entry 3 Byrd Richard · CIK 0001945298 · EVP & President Interventional 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,849 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:59 UTC |
Byrd RichardEVP & President Interventional
|
GrantCommon Stock | 2,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054344 · wk-form4_1764608369.xml · nonDerivative · entry 2 Byrd Richard · CIK 0001945298 · EVP & President Interventional 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,568 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:59 UTC |
Byrd RichardEVP & President Interventional
|
GrantCommon Stock | 6,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054344 · wk-form4_1764608369.xml · nonDerivative · entry 1 Byrd Richard · CIK 0001945298 · EVP & President Interventional 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,183 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:51 UTC |
Polen Thomas E JrChairman, CEO and President
|
GrantStock Appreciation Rights · Derivative | 165,581 | $0.00 Strike: $193.90 | $0.00 |
DisclosureSEC source: 0001628280-25-054339 · wk-form4_1764607898.xml · derivative · entry 3 Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,581 Underlying: Common Stock · 165,581 shares Expires 2035-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2026. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:51 UTC |
Polen Thomas E JrChairman, CEO and President
|
Tax withholdingCommon Stock | 17,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054339 · wk-form4_1764607898.xml · nonDerivative · entry 2 Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,471 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:51 UTC |
Polen Thomas E JrChairman, CEO and President
|
GrantCommon Stock | 22,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054339 · wk-form4_1764607898.xml · nonDerivative · entry 1 Polen Thomas E Jr · CIK 0001621793 · Chairman, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,892 F1 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:54 UTC |
Muhsin BilalEVP & President Connected Care
|
GrantCommon Stock | 9,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054341 · wk-form4_1764608084.xml · nonDerivative · entry 1 Muhsin Bilal · CIK 0001734507 · EVP & President Connected Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,751 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 16:46 UTC |
Spikner Pamela L.SVPController & Chief Acct Off
|
GrantCommon Stock | 1,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054337 · wk-form4_1764607610.xml · nonDerivative · entry 1 Spikner Pamela L. · CIK 0002012329 · SVPController & Chief Acct Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,916 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 07, 2025 Filed Nov 7, 2025 22:36 UTC |
SCOTT BERTRAM LDirector
|
SaleCommon Stock | 217 | $176.58 | $38,317.86 |
DisclosureSEC source: 0001628280-25-050735 · wk-form4_1762555003.xml · nonDerivative · entry 1 SCOTT BERTRAM L · CIK 0001221780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,816 Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 01:41 UTC |
Byington Carrie LDirector
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 34 | $178.71 | $6,076.14 |
DisclosureSEC source: 0001628280-25-049179 · wk-form4_1762306858.xml · derivative · entry 1 Byington Carrie L · CIK 0001890265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,675 Underlying: Common Stock · 34 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 01:36 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 168 | $178.71 | $30,023.28 |
DisclosureSEC source: 0001628280-25-049175 · wk-form4_1762306611.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,316 Underlying: Common Stock · 168 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 15:58 UTC |
Feld MichaelEVP & President, Life Sciences
|
SaleCommon Stock | 57 | $186.01 | $10,602.57 |
DisclosureSEC source: 0001628280-25-046645 · wk-form4_1761667077.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,245 Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 20:58 UTC |
Feld MichaelEVP & President, Life Sciences
|
SaleCommon Stock | 58 | $181.03 | $10,499.74 |
DisclosureSEC source: 0001628280-25-043134 · wk-form4_1759179496.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,302 Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 16:36 UTC |
Fraser ClaireDirector
|
SaleCommon Stock | 917 | $187.50 | $171,937.50 |
DisclosureSEC source: 0001382031-25-000007 · wk-form4_1757608610.xml · nonDerivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,226 Read SEC document |
| September 01, 2025 Filed Sep 2, 2025 23:57 UTC |
DelOrefice ChristopherEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0000010795-25-000091 · wk-form4_1756857449.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,221 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1. Read SEC document |
| September 01, 2025 Filed Sep 2, 2025 23:54 UTC |
Byrd RichardEVP & President Interventional
|
Tax withholdingCommon Stock | 216 | $0.00 | $0.00 |
DisclosureSEC source: 0000010795-25-000088 · wk-form4_1756857272.xml · nonDerivative · entry 1 Byrd Richard · CIK 0001945298 · EVP & President Interventional 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,736 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 19:41 UTC |
Feld MichaelEVP & President, Life Sciences
|
SaleCommon Stock | 57 | $197.99 | $11,285.43 |
DisclosureSEC source: 0000010795-25-000085 · wk-form4_1756237265.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,360 Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 17:26 UTC |
Feld MichaelEVP & President, Life Sciences
|
Tax withholdingCommon Stock | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000010795-25-000083 · wk-form4_1755883561.xml · nonDerivative · entry 1 Feld Michael · CIK 0002034349 · EVP & President, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,417 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards. Read SEC document |
| August 11, 2025 Filed Aug 11, 2025 20:15 UTC |
HAYES GREGORYDirector
|
PurchaseCommon Stock | 5,250 | $191.57 | $1,005,742.50 |
DisclosureSEC source: 0000010795-25-000081 · wk-form4_1754943349.xml · nonDerivative · entry 1 HAYES GREGORY · CIK 0001225946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,046 Read SEC document |
| August 08, 2025 Filed Aug 8, 2025 22:56 UTC |
Fraser ClaireDirector
|
SaleCommon Stock | 863 | $192.30 | $165,954.90 |
DisclosureSEC source: 0000010795-25-000079 · wk-form4_1754693814.xml · nonDerivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,143 Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 20:58 UTC |
Jones Christopher Ian MontagueDirector
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 168 | $178.25 | $29,946.00 |
DisclosureSEC source: 0000010795-25-000077 · wk-form4_1754600299.xml · derivative · entry 1 Jones Christopher Ian Montague · CIK 0001292762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,089 Underlying: Common Stock · 168 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 20:51 UTC |
Byington Carrie LDirector
|
GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 34 | $178.25 | $6,060.50 |
DisclosureSEC source: 0000010795-25-000075 · wk-form4_1754599899.xml · derivative · entry 1 Byington Carrie L · CIK 0001890265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,632 Underlying: Common Stock · 34 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.